Table 5.
Clinical Trials with Belinostat (PXD101) As Single Drug
| NCT number | Recruitment | Study results | Conditions | Phases | Funded by |
|---|---|---|---|---|---|
| NCT00413075 | Completed | No results available | Solid tumor|Lymphoma | 1 | Industry |
| NCT00274651 | Completed | No results available | Cutaneous T-cell lymphoma|Peripheral T-cell lymphoma|Non-Hodgkin's lymphoma | 2 | Industry |
| NCT00865969 | Active, not recruiting | No results available | Peripheral T-cell lymphoma | 2 | Industry |
| NCT00301756 | Active, not recruiting | No results available | Fallopian tube cancer|Primary peritoneal cavity cancer|Ovarian tumor|Ovarian epithelial cancer | 2 | NIH |
| NCT01583777 | Not yet recruiting | No results available | Advanced cancer | 1 | Industry |
| NCT00321594 | Completed | No results available | Adult primary hepatocellular carcinoma|Liver cancer | 1/2 | NIH |
| NCT00589290 | Active, not recruiting | Has results | Thymoma|Thymic carcinoma | 2 | NIH |
| NCT01273155 | Recruiting | No results available | Neoplasms|Lymphomas | 1 | NIH |
| NCT00357162 | Completed | Has results | de Novo, previously, secondary MDS | 2 | NIH |
| NCT00357032 | Completed | No results available | AML | 2 | NIH |
| NCT00365053 | Completed | No results available | Mesothelioma | 2 | NIH |
| NCT00303953 | Completed | Has results | Recurrent adult Burkitt lymphoma|Recurrent adult DLCL | 2 | NIH |
DLCL, diffuse large cell lymphoma.